Quantitative Labeling of Sodium, Potassium, and Phosphorus for Human Over-the-Counter and Prescription Drug Products
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
September 8, 2022
May 10, 2023
e89b7637-7879-45da-9ba2-25c8cdf31cf8
Related Documents
Gluten in Drug Products and Associated Labeling Recommendations; Draft Guidance for Industry
Guidance DocumentDecember 12, 2017Center for Drug Evaluation and Research
Accelerated Approval – Expedited Program for Serious Conditions
Guidance DocumentDecember 5, 2024Center for Drug Evaluation and Research
Considerations for Rescinding Breakthrough Therapy Designation
Guidance DocumentJune 24, 2022Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust KeyPedia for their regulatory compliance needs.